Amy Moss Trombly
CIK 1384640 · Chief Executive Officer · last filed 2026-01-02
Amy Moss Trombly is a Chief Executive Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for SNOA, was dated Jan 2, 2026. Current disclosed insider exposure totals $167.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$167.4K
2
11
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNOA | Chief Executive Officer | 153,586 | $1.09 | $167.4K | $0 | 9 | 2026-01-02 |
| Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted | Chief Executive Officer | — | — | — | $0 | 1 | 2020-01-03 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-02 | SNOA | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | SNOA | Grant (A) | — | $0 | EDGAR |
| 2025-01-03 | SNOA | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | SNOA | Grant (A) | +53,586 | $0 | EDGAR |
| 2023-12-29 | SNOA | Grant (A) | — | $0 | EDGAR |
| 2023-07-03 | SNOA | Grant (A) | +100,000 | $0 | EDGAR |
| 2022-12-30 | SNOA | Grant (A) | — | $0 | EDGAR |
| 2022-01-14 | SNOA | Grant (A) | — | $0 | EDGAR |
| 2021-01-08 | SNOA | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted | Grant (A) | — | $0 | EDGAR |